氟氢可体松

氟氢可体松(Fludrocortisone),商品名包括富能锭(Florinef)等,是一种口服的皮质类固醇,用于治疗先天性肾上腺增生症直立性低血压肾上腺功能不全[1] [2]。绐疗肾上腺功能不全时,常与氢羟肾上腺皮质素并用[2]。最常见的是醋酸盐化合物[3]

氟氢可体松
临床资料
商品名英语Drug nomenclatureAstonin, Astonin-H, others
其他名称StC-1400; 9α-Fluorohydrocortisone; 9α-Fluorocortisol; 9α-Fluoro-17α-hydroxycorticosterone; 9α-Fluoro-11β,17α,21-trihydroxypregn-4-ene-3,20-dione
AHFS/Drugs.comMonograph
怀孕分级
  • C
给药途径口服给药
药物类别英语Drug class皮质类固醇糖皮质激素盐皮质激素
ATC码
法律规范状态
法律规范
药物动力学数据
血浆蛋白结合率
药物代谢肝脏
生物半衰期3.5小时
识别信息
  • (8S,9R,10S,11S,13S,14S,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one
CAS号127-31-1  checkY
U0476M545B  checkY
PubChem CID
PubChem SID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
PDB配体ID
CompTox Dashboard英语CompTox Chemicals Dashboard (EPA)
ECHA InfoCard100.004.395 编辑维基数据链接
化学信息
化学式C21H29FO5
摩尔质量380.46 g·mol−1
3D模型(JSmol英语JSmol
  • O=C(CO)[C@]3(O)[C@]2(C[C@H](O)[C@]4(F)[C@@]1(/C(=C\C(=O)CC1)CC[C@H]4[C@@H]2CC3)C)C
  • InChI=1S/C21H29FO5/c1-18-7-5-13(24)9-12(18)3-4-15-14-6-8-20(27,17(26)11-23)19(14,2)10-16(25)21(15,18)22/h9,14-16,23,25,27H,3-8,10-11H2,1-2H3/t14-,15-,16-,18-,19-,20-,21-/m0/s1 checkY
  • Key:AAXVEMMRQDVLJB-BULBTXNYSA-N checkY
醋酸氟氢可体松
临床资料
商品名英语Drug nomenclatureCortineff, Florinef, Florinefe, Fludrocortison, others
其他名称Fluorohydrocortisone acetate; 9α-Fluorohydrocortisone 21-acetate; 9α-Fluoro-17α-hydroxycorticosterone 21-acetate; 9α-Fluoro-11β,17α,21-trihydroxypregn-4-ene-3,20-dione 21-acetate
给药途径口服给药
药物类别英语Drug class皮质类固醇糖皮质激素盐皮质激素
药物动力学数据
药物代谢肝脏
识别信息
  • [2-[(8S,9R,10S,11S,13S,14S,17R)-9-fluoro-11,17-dihydroxy-10,13-dimethyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate
CAS号514-36-3
PubChem CID
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard英语CompTox Chemicals Dashboard (EPA)
ECHA InfoCard100.004.395 编辑维基数据链接
化学信息
化学式C23H31FO6
摩尔质量422.49 g·mol−1
3D模型(JSmol英语JSmol
熔点260至262 °C(500至504 °F) (dec.)
  • CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)CC[C@@]43C)F)O)C)O
  • InChI=1S/C23H31FO6/c1-13(25)30-12-19(28)22(29)9-7-16-17-5-4-14-10-15(26)6-8-20(14,2)23(17,24)18(27)11-21(16,22)3/h10,16-18,27,29H,4-9,11-12H2,1-3H3/t16-,17-,18-,20-,21-,22-,23-/m0/s1
  • Key:SYWHXTATXSMDSB-GSLJADNHSA-N

常见副作用包括高血压、水肿、心脏衰竭低血钾[2]。其他严重副作用包括免疫功能低下白内障、肌肉无力和情绪变化[2]怀孕期间使用的安全还未明确[4]。氟氢可体松主要是一种盐皮质激素,但也有糖皮质激素作用[2]

氟氢可体松于1953年取得专利[5]。名列世界卫生组织基本药物清单[6]

参考文献

  1. ^ J. Elks. The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. 14 November 2014: 558–. ISBN 978-1-4757-2085-3. (原始内容存档于5 November 2017). 
  2. ^ 2.0 2.1 2.2 2.3 2.4 Fludrocortisone Acetate. The American Society of Health-System Pharmacists. [8 December 2016]. (原始内容存档于5 July 2017). 
  3. ^ Richard O. Day; Daniel E. Furst; Piet L.C.M. van Riel; Barry Bresnihan. Antirheumatic Therapy: Actions and Outcomes. Springer Science & Business Media. 30 May 2010: 21–. ISBN 978-3-7643-7726-7. (原始内容存档于5 November 2017). 
  4. ^ Fludrocortisone Use During Pregnancy | Drugs.com. www.drugs.com. [24 December 2016]. (原始内容存档于24 December 2016). 
  5. ^ Fischer, Janos; Ganellin, C. Robin. Analogue-based Drug Discovery. John Wiley & Sons. 2006: 484. ISBN 9783527607495. (原始内容存档于2017-11-05) (英语). 
  6. ^ World Health Organization. World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. 2019. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO. 

外部连节

  • Fludrocortisone. Drug Information Portal. U.S. National Library of Medicine.